Christopher B. Begley - 31 Mar 2025 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Reporting relationship: Director
Issuer ticker: ZBH
Reported as of: 31 Mar 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Apr 2025, 16:11:50 UTC
Prior SEC filing: 03 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Matthew R. St. Louis, Attorney-in-Fact for Christopher B. Begley (power of attorney previously filed)

Key filing fact

Christopher B. Begley filed Form 4 for ZIMMER BIOMET HOLDINGS, INC. (ZBH) on 02 Apr 2025.

Key facts

This page summarizes Christopher B. Begley's Form 4 filing for ZIMMER BIOMET HOLDINGS, INC. (ZBH).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Apr 2025, 16:11.

Change

Previous filing in this sequence was filed on 03 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZBH transaction Derivative

Phantom Stock Units

Award

Transaction value: $0
Shares: +533
Change %: +2.5%
Price: $0.000000
Shares after: 21,938
Date: 31 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 533
Exercise price: $112.51
Footnotes: F1, F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Footnote F2

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Footnote F3

Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

Footnote F4

Includes 45.338 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.